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Although the lung, liver, or bones are the most common
location for distant metastases in breast cancer patients,
metastases to the intestinal tract are very rarely recognized in
the clinic. We will present an unusual case of colonic metas-
tasis from a carcinoma of the breast that mimics a primary
intestinal cancer, along with a through review of English
language medical literature. Despite the fact that isolated
gastrointestinal (GI) metastases are very rare and much less
common than benign disease processes or second primaries of
the intestinal tract in patients with a history of breast cancer,
metastatic disease should be given consideration whenever a
patient experiences GI symptoms.
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INTRODUCTION
Distant metastasis is the most common cause of
death in breast cancer patients and these sites
often occur in the bone, lungs, brain, and liver.
However, metastasis to the GI tract is an unusual
presentation despite the fact that intestinal tract
metastases are not rare at post mortem examina-
tion.
1-4 The most frequent sites of GI tract involve-
ment are the stomach and the small intestine,
while colorectal metastases is very rare.
3,5 Colorec-
tal metastases can mimic a primary large bowel
cancer and may present confusing diagnostic pro-
blems.
2,6
In this paper, the case of a 43 year-old woman
with breast carcinoma developing into colonic
metastasis (this was recognized antemortem) is
described.
CASE REPORT
A 43-year-old woman underwent right modi-
fied radical mastectomy and an axillary curettage
in 1997 for a ductal and lobular mixed type
carcinoma. She was staged as T2N0M0 postopera-
tively and found to have been estrogen receptor
(ER) negative, progesterone receptor (PR) positive.
Following six cycles of adjuvant chemotherapy,
she was then treated with a daily dosage of 20 mg
tamoxifen (TMX). Thirty-six months after the
operation, she began to complain of pelvic pain.
A bone scan revealed an increased uptake in the
right acetebular area and left proximal femur. The
TMX was stopped and a luteinizing hormone-
releasing hormone analog (goserelin 3.6 mg
monthly) was started due to the metastatic
evidence in the bone scan. She also received
palliative radiotherapy on the metastatic areas at
a dosage of 3000 cGy in ten fractions.
Six months after the diagnosis of bone meta-
stases, the patient was admitted to the regional
State hospital because of a one-week history of
alteration in her bowel habits, abdominal colicky
pain and distension, and nausea/vomiting that
had aggravated in the previous 2 days. There was
no history of hematemesis, melena, fever, or pre-
vious abdominal surgery. On physical examina-
tion, the abdomen was distended and bowel
sounds were present. There was a tenderness and
mild guarding of the lower abdomen. A tender
mass was palpated in the right lower quadrant.
Rectal examination revealed no abnormalities. No
rash, lymphadenopathy, or hernia was detected.
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Stool examination for occult blood was negative
and tumor markers (CEA, CA19-9) were normal.
The erythrocyte sedimentation rate was 14 mm
per hour and white blood cell count was 10.6×10
3
per cubic millimeter. Other blood chemical and
enzyme values were normal.
A plain film procedure done in the upright
position revealed distended loops of gut with
fluid levels being present. Abdominal ultrasono-
graphy did not reveal the nature of the mass.
Then, abdominal computed tomographic scan
showed marked ascending colonic wall thickening
extending from the cecum to the proximal portion
of the ascending colon, and this caused a nar-
rowing of the lumen and also an infiltration of the
pericolic fat (Fig. 1). The scan also revealed dis-
tended small bowel loops of gut, free fluid
retention in the latero-choanal fascia, perihepatic,
and right paracolic gutter and regional lymph
nodes smaller than 1 cm in diameter. The patient
underwent an exploratory laparotomy, which
revealed a large, firm mass in the right abdomen
and enlarged indurate lymph nodes in the
mesocolon. The distal part of the terminal ileum
and the right colon were thickened and indurated.
A right-hemicolectomy with end-to-end anasto-
mosis was performed. No evidence of liver, ovari-
an, uterine, or peritoneal involvement was ob-
served. The postoperative course of recovery was
uneventful.
On the examination of the right-hemicolectomy
specimen, a thickening and rigidity of the colonic
wall extending from the cecum to 6 cm segment
of the ascending colon was observed. Microscopic
examination revealed a diffuse infiltration by neo-
plastic cells of the intestinal wall. The tumor cells
had invaded the muscularis propria and also the
serosa. Seven of the twenty lymph nodes sampled
were invaded by tumor. The gross appearance
was fully consistent with that of a primary colo-
rectal carcinoma with secondary involvement of
local lymph nodes. However, because of a
morphological similarity (Fig. 2A, B) to the pre-
vious breast cancer and the absence of dysplasia
in adjacent colonic epithelium, the histological
Fig. 2. (A) Mastectomy specimen obtained in 1997, showing infiltrating ductal and lobular mixed type carcinoma (H&E,
× 100). (B). Right-hemicolectomy specimen, showing an intact mucosal epithelium and muscular and serosal involvement
with tumor cells. The cells presenting characteristic pattern of metastatic lobular carcinoma, (H&E, ×100).
Fig. 1. CT scan demonstrates a heterogeneous soft-tissue
mass that appeared to fill the cecum and the proximal
portion of the ascending colon and dilated distended
loops of gut with fluid levels.
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findings confirmed metastatic carcinoma. Unlike
the original tumor, it was ER positive and PR
negative. The cells stained positively for cytokera-
tin identifying their epithelial origin, and also
gross cystic disease fluid protein-15 (GCDFP-15)
(Fig. 3). After the operation, the patient was refer-
red to our unit with the diagnosis of metastatic
breast cancer. Postoperative abdominal computed
tomographic scan and tumor markers (CEA, CA
15-3) were normal. She received 6 cycles of
chemotherapy using 5-fluorouracil, adriamycin,
and cyclophosphamide. Following her chemo-
therapy, megestrol acetate at a dosage of 160 mg
daily was started. The patient is still alive 7
months after the diagnosis of colonic metastases.
DISCUSSION
Only 5% to 15% of breast cancer patients have
distant metastases at diagnosis.
7 Although the
lymph nodes, lung, liver, or bones are the most
common locations for distant metastases, a few
cases of GI tract involvement have been reported.
4
Metastases to the intestinal tract from breast carci-
noma are very rarely recogniozed in the clinic
setting and its true incidence is not known.
However, sixteen percent of patients with breast
cancer have GI metastases at postmortem exami-
nation.
1 Of these, the most frequent organ in-
volved is the stomach with colon involvement
being less common. In a review of the literature,
metastatic breast cancer that spread to the colon
was found in only 20 of 720 (3%) cases.
8 In most
instances, breast cancer metastatic to the large
bowel that's detected during the life of patients
have been described as case reports
2-5,9-11 (Table 1).
Taal et al. reported 17 cases of colorectal meta-
stasis from breast cancer over a 15-year period.
5
The primary tumor was usually lobular carcinoma
Table 1. English Language Medical Literature Review for Breast Cancer Patients with Colonic Metastases
Reference (No.)
Patients
(n)
Age
(yrs)
Time from
diagnosis
Primary breast
cancer histology
Treatment Outcome
Taal et al.*(5) 17 60 53 months Lobular 15 Resection + Systemic (3) 16 months
Ductal 1 Radiotherapy (2)
NR 1 Systemic (12)
Schwarz et al. (3) 1 78 0.25 years Ductal/Lobular Resection NED (19 months)
Koutsomanis et al. (6) 1 65 4 years Ductal Resection + Systemic NED (36 months)
Yokota et al. (2) 1 57 10 years Ductal Resection NR
Vaidya et al. (9) 1 56 5 years Ductal Resection + Systemic NR
Rabau et al. (4) 1 53 7 years Lobular Resection NR
Gifaldi et al. (10) 1 86 10 years Lobular Resection + Systemic NR
Voravud et al. (11) 1 74 0.5 years Lobular Resection NR
Current case 1 38 5 years Ductal/Lobular Resection + Systemic NED (7 months)
*Data of colonic and rectal metastases together (17 patients).
Median (range 42 - 76).
Median survival.
NED, no evidence of disease; NR, not reported.
Fig. 3. Positive staining with anti-GCDFP-15 (×100).Metastasis from Carcinoma of the Breast
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and patients presented their secondary condition
on an average of 53 months after primary treat-
ment. Their average survival time was 16 months.
Schwarz et al. reported 7 cases with metastatic
breast cancer mimicking a GI tract primary.
3 The
average interval between breast cancer and GI
metastasis was 6 years and the average survival
time after presenting GI symptoms was 12
months. Lobular carcinoma was the predominant
histological type and only one out of 7 patients
had colonic metastases. For the current case, the
interval between primary tumor diagnosis and
colonic metastases was 59 months, and she is still
alive 7 months after the diagnosis of colonic me-
tastases.
Because of its rarity, its nonspecific clinical pre-
sentation and the variable radiographic features,
the diagnosis of intestinal metastasis is difficult. In
patients with history of breast cancer, isolated GI
metastases are less common than benign disease
processes or second primaries of the GI tract.
12
Therefore, a history of malignancy does not
necessary imply GI tract metastases. Diagnostic
imaging is rarely specific. In order to differentiate
primary and metastatic tumors involving the GI
tract, histopathological comparison of mammary
and GI specimens is mandatory. The morpholo-
gical similarity to the previous breast cancer and
the absence of dysplasia in adjacent colonic epi-
thelium suggests a metastatic growth. As seen in
our patient, in the presence of mixed ductal and
lobular infiltrative components within the pri-
mary, the metastatic growth pattern seems to
favor lobular component, but again the mecha-
nisms remain unclear.
3 Immunohistochemistry
may also be useful in reaching the correct diag-
nosis. The ER or PR and GCDFP-15 are usually
positive in metastatic breast carcinomas.
13,14 But it
has been reported that up to 30 - 70% of primary
colonic cancers are estrogen receptor positive.
15
The patient may present with a variety of symp-
toms including asymptomatic abdominal mass,
slight to severe pain or those symptoms sug-
gesting an inflammatory bowel disease or primary
GI cancer.
2 Acute presentation with perforation,
GI bleeding or bowel obstruction has also been
reported.
3 Obstruction of the colon does not com-
monly occur in cases of right sided lesions. As the
lumen of the cecum is large, obstruction due to a
primary malignant tumor is rare. However, a
circumferential tumor can obliterate the lumen
and cause an obstruction. In the current case, the
patient presented with evidence of a partial bowel
obstruction and abdominal surgery was per-
formed for getting an exact diagnosis and also as
a palliative treatment.
Surgery, radiation, and systemic therapy all
have a place in the treatment of metastatic breast
cancer. While local tumors are typically treated
first with surgery and radiation (with an optional
systemic therapy as an adjuvant), a multifocal
disease process is usually treated with a systemic
therapy. But the intestinal involvement of meta-
static breast cancer suggests a systemic disease in
most cases. Systemic hormonal or chemotherapy,
either alone or as an adjunct to surgery, produces
a favorable response in patients with GI meta-
stases of breast cancer.
2,3,5,6 If a patient presents
with acute or subacute symptoms as in our case,
surgery is necessary for palliation and sometimes
it is used for an exact diagnosis. Survival after
diagnosis of GI metastases is poor with few pa-
tients surviving beyond two years. The average
survival from time of recurrence is 12 to 16
months.
3,5
Isolated GI metastases are very rare and are less
common than a benign disease processes or
second primaries of the intestinal tract in those
patients with a history of breast cancer. But an
alert physician should always consider the pos-
sibility of a metastatic disease process whenever
a patient with such a medical history experiences
and presents with GI symptoms.
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